Glucocorticoid receptor and treatment of psychotic major depression.
The National Center for Drug Screening, Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China.
Xin
X
Hui
Cai-hong
CH
Zhou
Ming-wei
MW
Wang
D000818:Animals; D001921:Brain / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008797:Metyrapone / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D011743:Pyrimidines / Q000627:therapeutic use; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000378:metabolism*
D011743:Pyrimidines; C412383:R 121919; D018019:Receptors, Corticotropin-Releasing Hormone; D011965:Receptors, Glucocorticoid; D015735:Mifepristone; D003687:Dehydroepiandrosterone; D008797:Metyrapone